Khosravi-Far R - Search Results

1

FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Jagani Z, Singh A, Khosravi-Far R. Jagani Z, et al. Biochim Biophys Acta. 2008 Jan;1785(1):63-84. doi: 10.1016/j.bbcan.2007.10.003. Epub 2007 Oct 16. Biochim Biophys Acta. 2008. PMID: 17980712 Free PMC article. Review.

2

Apoptotic pathways in tumor progression and therapy.

Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R. Melet A, et al. Adv Exp Med Biol. 2008;615:47-79. doi: 10.1007/978-1-4020-6554-5_4. Adv Exp Med Biol. 2008. PMID: 18437891 Review.

3

Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors.

Jagani Z, Song K, Kutok JL, Dewar MR, Melet A, Santos T, Grassian A, Ghaffari S, Wu C, Yeckes-Rodin H, Ren R, Miller K, Khosravi-Far R. Jagani Z, et al. Cancer Res. 2009 Aug 15;69(16):6546-55. doi: 10.1158/0008-5472.CAN-09-0605. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654305 Free PMC article.

4

Harnessing the tumor suppressor function of FOXO as an alternative therapeutic approach in cancer.

Singh A, Plati J, Khosravi-Far R. Singh A, et al. Curr Drug Targets. 2011 Aug;12(9):1311-21. doi: 10.2174/138945011796150271. Curr Drug Targets. 2011. PMID: 21443464 Review.

5

Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor.

Ghaffari S, Jagani Z, Kitidis C, Lodish HF, Khosravi-Far R. Ghaffari S, et al. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6523-8. doi: 10.1073/pnas.0731871100. Epub 2003 May 15. Proc Natl Acad Sci U S A. 2003. PMID: 12750477 Free PMC article.

6

Cancer stem cells and impaired apoptosis.

Jagani Z, Khosravi-Far R. Jagani Z, et al. Adv Exp Med Biol. 2008;615:331-44. doi: 10.1007/978-1-4020-6554-5_15. Adv Exp Med Biol. 2008. PMID: 18437901 Review.

7

Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT.

Singh A, Ye M, Bucur O, Zhu S, Tanya Santos M, Rabinovitz I, Wei W, Gao D, Hahn WC, Khosravi-Far R. Singh A, et al. Mol Biol Cell. 2010 Mar 15;21(6):1140-52. doi: 10.1091/mbc.e09-09-0795. Epub 2010 Jan 28. Mol Biol Cell. 2010. PMID: 20110348 Free PMC article.

8

Regulation of tumor angiogenesis by thrombospondin-1.

Ren B, Yee KO, Lawler J, Khosravi-Far R. Ren B, et al. Biochim Biophys Acta. 2006 Apr;1765(2):178-88. doi: 10.1016/j.bbcan.2005.11.002. Epub 2005 Dec 21. Biochim Biophys Acta. 2006. PMID: 16406676 Review.

9

Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.

Bucur O, Stancu AL, Goganau I, Petrescu SM, Pennarun B, Bertomeu T, Dewar R, Khosravi-Far R. Bucur O, et al. PLoS One. 2013 Oct 14;8(10):e77390. doi: 10.1371/journal.pone.0077390. eCollection 2013. PLoS One. 2013. PMID: 24155950 Free PMC article.

10

Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker.

Dewar R, Chen ST, Yeckes-Rodin H, Miller K, Khosravi-Far R. Dewar R, et al. Cancer Biol Ther. 2011 Mar 15;11(6):552-8. doi: 10.4161/cbt.11.6.14675. Epub 2011 Mar 15. Cancer Biol Ther. 2011. PMID: 21282974 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters